Zheng B - Search Results

1

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice.

Qu D, Zheng B, Yao X, Guan Y, Yuan ZH, Zhong NS, Lu LW, Xie JP, Wen YM. Qu D, et al. Among authors: zheng b. Vaccine. 2005 Jan 4;23(7):924-31. doi: 10.1016/j.vaccine.2004.07.031. Vaccine. 2005. PMID: 15603894 Free PMC article.

2

Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients.

Yao X, Zheng B, Zhou J, Xu DZ, Zhao K, Sun SH, Yuan ZH, Wen YM. Yao X, et al. Among authors: zheng b. Vaccine. 2007 Feb 26;25(10):1771-9. doi: 10.1016/j.vaccine.2006.11.019. Epub 2006 Nov 27. Vaccine. 2007. PMID: 17224217

3

Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.

Li BJ, Tang Q, Cheng D, Qin C, Xie FY, Wei Q, Xu J, Liu Y, Zheng BJ, Woodle MC, Zhong N, Lu PY. Li BJ, et al. Nat Med. 2005 Sep;11(9):944-51. doi: 10.1038/nm1280. Epub 2005 Aug 21. Nat Med. 2005. PMID: 16116432 Free PMC article.

4

Mutational analysis of the "turn" of helix clamp motif of HIV-1 reverse transcriptase.

Wang YX, Zhang HJ, Xu J, Zheng BJ, Wen YM. Wang YX, et al. Biochem Biophys Res Commun. 2008 Dec 19;377(3):915-20. doi: 10.1016/j.bbrc.2008.10.106. Epub 2008 Oct 29. Biochem Biophys Res Commun. 2008. PMID: 18976635

5

Interaction between SARS-CoV helicase and a multifunctional cellular protein (Ddx5) revealed by yeast and mammalian cell two-hybrid systems.

Chen JY, Chen WN, Poon KM, Zheng BJ, Lin X, Wang YX, Wen YM. Chen JY, et al. Arch Virol. 2009;154(3):507-12. doi: 10.1007/s00705-009-0323-y. Epub 2009 Feb 18. Arch Virol. 2009. PMID: 19224332 Free PMC article.

6

Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus.

Zheng BJ, Guan Y, Tang Q, Du C, Xie FY, He ML, Chan KW, Wong KL, Lader E, Woodle MC, Lu PY, Li B, Zhong N. Zheng BJ, et al. Antivir Ther. 2004 Jun;9(3):365-74. Antivir Ther. 2004. PMID: 15259899

7

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.

Du L, Zhao G, He Y, Guo Y, Zheng BJ, Jiang S, Zhou Y. Du L, et al. Vaccine. 2007 Apr 12;25(15):2832-8. doi: 10.1016/j.vaccine.2006.10.031. Epub 2006 Oct 30. Vaccine. 2007. PMID: 17092615 Free PMC article.

8

The y271 and i274 amino acids in reverse transcriptase of human immunodeficiency virus-1 are critical to protein stability.

Zhang HJ, Wang YX, Wu H, Jin DY, Wen YM, Zheng BJ. Zhang HJ, et al. PLoS One. 2009 Jul 3;4(7):e6108. doi: 10.1371/journal.pone.0006108. PLoS One. 2009. PMID: 19578544 Free PMC article.

9

Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma).

Zheng B, He ML, Wong KL, Lum CT, Poon LL, Peng Y, Guan Y, Lin MC, Kung HF. Zheng B, et al. J Interferon Cytokine Res. 2004 Jul;24(7):388-90. doi: 10.1089/1079990041535610. J Interferon Cytokine Res. 2004. PMID: 15296649

10

Inhibition of SARS-associated coronavirus infection and replication by RNA interference.

He ML, Zheng B, Peng Y, Peiris JS, Poon LL, Yuen KY, Lin MC, Kung HF, Guan Y. He ML, et al. Among authors: zheng b. JAMA. 2003 Nov 26;290(20):2665-6. doi: 10.1001/jama.290.20.2665. JAMA. 2003. PMID: 14645307 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,652 results

Search Page

Filters